α2-Adrenergic Receptor in Liver Fibrosis: Implications for the Adrenoblocker Mesedin
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Cells : open access journal 9(2), 10.3390/cells9020456
- Ereignis
-
Veröffentlichung
- (wo)
-
Aachen
- (wer)
-
Universitätsbibliothek der RWTH Aachen
- (wann)
-
2020
- Urheber
-
Schwinghammer, Ute A.
Melkonyan, Magda M.
Hunanyan, Lilit
Tremmel, Roman
Weiskirchen, Ralf
Borkham-Kamphorst, Erawan
Schaeffeler, Elke
Seferyan, Torgom
Mikulits, Wolfgang
Yenkoyan, Konstantin
Schwab, Matthias
Danielyan, Lusine
- DOI
-
10.18154/RWTH-CONV-242155
- URN
-
urn:nbn:de:101:1-2021032316514805986968
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:55 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Schwinghammer, Ute A.
- Melkonyan, Magda M.
- Hunanyan, Lilit
- Tremmel, Roman
- Weiskirchen, Ralf
- Borkham-Kamphorst, Erawan
- Schaeffeler, Elke
- Seferyan, Torgom
- Mikulits, Wolfgang
- Yenkoyan, Konstantin
- Schwab, Matthias
- Danielyan, Lusine
- Universitätsbibliothek der RWTH Aachen
Entstanden
- 2020
Ähnliche Objekte (12)
Cell therapy in liver fibrosis
Magnetic-assisted treatment of liver fibrosis
Special Issue "Liver Fibrosis: Mechanisms, Targets, Assessment and Treatment"
Physalin B attenuates liver fibrosis via suppressing LAP2 alpha-HDAC1 mediated deacetylation of glioma-associated oncogene 1 and hepatic stellate cell activation
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis : mechanisms, treatment and prevention
The Cape Gooseberry Constituent Physalin B Ameliorates Nonalcoholic Steatohepatitis and Attenuates Liver Fibrosis
Cellular Mechanisms of Liver Fibrosis
Autophagy in Parenchymal and Non-Parenchymal Liver Cells
Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis"
Differentielle Genaktivität in v-myc-transformierten Wachtelfibroblasten
Identification and functional analysis of the LIM domain protein CRP2, a marker of hepatic stellate cells
Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis II"
Cell therapy in liver fibrosis
Magnetic-assisted treatment of liver fibrosis
Special Issue "Liver Fibrosis: Mechanisms, Targets, Assessment and Treatment"
Physalin B attenuates liver fibrosis via suppressing LAP2 alpha-HDAC1 mediated deacetylation of glioma-associated oncogene 1 and hepatic stellate cell activation
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis : mechanisms, treatment and prevention
The Cape Gooseberry Constituent Physalin B Ameliorates Nonalcoholic Steatohepatitis and Attenuates Liver Fibrosis
Cellular Mechanisms of Liver Fibrosis
Autophagy in Parenchymal and Non-Parenchymal Liver Cells
Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis"
Differentielle Genaktivität in v-myc-transformierten Wachtelfibroblasten
Identification and functional analysis of the LIM domain protein CRP2, a marker of hepatic stellate cells
Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis II"
Cell therapy in liver fibrosis
Magnetic-assisted treatment of liver fibrosis
Special Issue "Liver Fibrosis: Mechanisms, Targets, Assessment and Treatment"
Physalin B attenuates liver fibrosis via suppressing LAP2 alpha-HDAC1 mediated deacetylation of glioma-associated oncogene 1 and hepatic stellate cell activation
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis : mechanisms, treatment and prevention
The Cape Gooseberry Constituent Physalin B Ameliorates Nonalcoholic Steatohepatitis and Attenuates Liver Fibrosis
Cellular Mechanisms of Liver Fibrosis
Autophagy in Parenchymal and Non-Parenchymal Liver Cells
Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis"
Differentielle Genaktivität in v-myc-transformierten Wachtelfibroblasten
Identification and functional analysis of the LIM domain protein CRP2, a marker of hepatic stellate cells